This retrospective, multicenter study is designed to collect therapeutic data from all patients
diagnosed with primary inguino- femorally node- positive squamous cell vulvar cancer
(VSCC) and treated with surgical staging of the groin/s in 2017-2019 at the gynaecological
cancer centers participating in the AGO CaRE-1 Study.
This retrospective, multicenter study is designed to collect therapeutic data from all patients
diagnosed with primary inguino- femorally node- positive squamous cell vulvar cancer
(VSCC) and treated with surgical staging of the groin/s in 2017-2019 at the gynaecological
cancer centers participating in the AGO CaRE-1 Study.
